Last 12 months
Inside the activity.
0 purchase rows · 143 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 34 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 92 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2013 Filed Aug 27, 2013 21:03 UTC |
Pesicka Edward ASenior Vice President
|
Tax withholdingCommon Stock | 1,356 | $90.36 | $122,528.16 |
DisclosureSEC source: 0001127602-13-026107 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,134 Read SEC document |
| August 26, 2013 Filed Aug 27, 2013 21:05 UTC |
Malus Alan JExecutive Vice President
|
Tax withholdingCommon Stock | 1,425 | $90.36 | $128,763.00 |
DisclosureSEC source: 0001127602-13-026108 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,360 Read SEC document |
| August 26, 2013 Filed Aug 27, 2013 21:06 UTC |
Loewald Thomas WSenior Vice President
|
Tax withholdingCommon Stock | 970 | $90.36 | $87,649.20 |
DisclosureSEC source: 0001127602-13-026109 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,983 Read SEC document |
| August 26, 2013 Filed Aug 27, 2013 21:08 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 74 | $90.36 | $6,686.64 |
DisclosureSEC source: 0001127602-13-026111 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,942 Read SEC document |
| August 26, 2013 Filed Aug 27, 2013 21:10 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Tax withholdingCommon Stock | 532 | $90.36 | $48,071.52 |
DisclosureSEC source: 0001127602-13-026112 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,531 Read SEC document |
| August 26, 2013 Filed Aug 27, 2013 21:11 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 3,569 | $90.36 | $322,494.84 |
DisclosureSEC source: 0001127602-13-026114 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,912.53 Read SEC document |
| August 15, 2013 Filed Aug 16, 2013 20:33 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 4,000 | $91.11 | $364,440.00 |
DisclosureSEC source: 0001127602-13-025421 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,785 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2012. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.06 to $91.43, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2013 Filed Aug 8, 2013 20:24 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $46.56 | $0.00 |
DisclosureSEC source: 0001127602-13-024752 · form4.xml · derivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2019-11-21 F1 · balance_after: On November 21, 2009, the reporting person was granted an option to purchase 100,000 shares of common stock. The option vested in one installment based on TMO's satisfaction of certain performance criteria. Read SEC document |
| July 24, 2013 Filed Jul 25, 2013 20:23 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 80,700 | $0.00 Strike: $36.10 | $0.00 |
DisclosureSEC source: 0001127602-13-023429 · form4.xml · derivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,700 shares Expires 2016-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal installments on February 26, 2010, 2011 and 2012. Read SEC document |
| July 24, 2013 Filed Jul 25, 2013 20:23 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 80,700 | $91.00 | $7,343,700.00 |
DisclosureSEC source: 0001127602-13-023429 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,490 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2013. Read SEC document |
| July 24, 2013 Filed Jul 25, 2013 20:23 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 80,700 | $36.10 | $2,913,270.00 |
DisclosureSEC source: 0001127602-13-023429 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 29, 2013 Filed Jul 2, 2013 20:35 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 339.71 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-13-027144 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,804.41 Underlying: Common Stock · 339.71 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of June 29, 2013, at a price of $84.63 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of June 29, 2013, at a price of $84.63 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of June 29, 2013, at a price of $84.63 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| June 17, 2013 Filed Jun 18, 2013 19:47 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,534 | $0.00 Strike: $36.10 | $0.00 |
DisclosureSEC source: 0001127602-13-020713 · form4.xml · derivative · entry 6 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,534 shares Expires 2016-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in three equal installments on February 26, 2010, 2011 and 2012. Read SEC document |
| June 17, 2013 Filed Jun 18, 2013 19:47 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,225 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-13-020713 · form4.xml · derivative · entry 5 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,075 Underlying: Common Stock · 18,225 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2011, 2012, and 2013, and the next installment becomes exercisable on March 5, 2014. Read SEC document |
| June 17, 2013 Filed Jun 18, 2013 19:47 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 35,431 | $85.59 | $3,032,539.29 |
DisclosureSEC source: 0001127602-13-020713 · form4.xml · nonDerivative · entry 3 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,063 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2013. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.29 to $85.78, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2013 Filed Jun 18, 2013 19:47 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 9,534 | $36.10 | $344,177.40 |
DisclosureSEC source: 0001127602-13-020713 · form4.xml · nonDerivative · entry 2 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2013 Filed Jun 18, 2013 19:47 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 18,225 | $49.49 | $901,955.25 |
DisclosureSEC source: 0001127602-13-020713 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2013 Filed Jun 18, 2013 19:49 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 43,396 | $85.58 | $3,713,829.68 |
DisclosureSEC source: 0001127602-13-020714 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,481.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2013. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.21 to $85.77, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2013 Filed Jun 11, 2013 20:44 UTC |
LEWENT JUDY CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $58.40 | $0.00 |
DisclosureSEC source: 0001127602-13-020060 · form4.xml · derivative · entry 3 LEWENT JUDY C · CIK 0001140890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2015-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal installments on July 10, 2009, 2010 and 2011. Read SEC document |
| June 10, 2013 Filed Jun 11, 2013 20:44 UTC |
LEWENT JUDY CDirector
|
SaleCommon Stock | 15,000 | $85.19 | $1,277,850.00 |
DisclosureSEC source: 0001127602-13-020060 · form4.xml · nonDerivative · entry 2 LEWENT JUDY C · CIK 0001140890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,188 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2013. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.92 to $85.30, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2013 Filed Jun 11, 2013 20:44 UTC |
LEWENT JUDY CDirector
|
Exercise / conversionCommon Stock | 15,000 | $58.40 | $876,000.00 |
DisclosureSEC source: 0001127602-13-020060 · form4.xml · nonDerivative · entry 1 LEWENT JUDY C · CIK 0001140890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $58.40 | $0.00 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · derivative · entry 9 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2015-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in three equal installments on July 10, 2009, 2010 and 2011. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,980 | $0.00 Strike: $31.31 | $0.00 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · derivative · entry 8 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,980 shares Expires 2015-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 64,800 | $0.00 Strike: $32.30 | $0.00 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · derivative · entry 7 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,800 shares Expires 2015-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 62,200 | $0.00 Strike: $30.68 | $0.00 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · derivative · entry 6 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,200 shares Expires 2015-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
SaleCommon Stock | 167,980 | $85.28 | $14,325,334.40 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · nonDerivative · entry 5 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,490 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2013. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.80 to $85.54, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 25,000 | $58.40 | $1,460,000.00 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · nonDerivative · entry 4 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 15,980 | $31.31 | $500,253.90 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 64,800 | $32.30 | $2,093,040.00 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2013 Filed Jun 11, 2013 20:41 UTC |
Pesicka Edward ASenior Vice President
|
Exercise / conversionCommon Stock | 62,200 | $30.68 | $1,907,985.00 |
DisclosureSEC source: 0001127602-13-020059 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2013 Filed May 29, 2013 20:30 UTC |
HARRIS C MARTINDirector
|
SaleCommon Stock | 1,260 | $87.21 | $109,884.60 |
DisclosureSEC source: 0001127602-13-018629 · form4.xml · nonDerivative · entry 1 HARRIS C MARTIN · CIK 0001236982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,931 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:20 UTC |
Chai NelsonDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018272 · form4.xml · nonDerivative · entry 1 Chai Nelson · CIK 0001299914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,139 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:22 UTC |
HARRIS C MARTINDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018273 · form4.xml · nonDerivative · entry 1 HARRIS C MARTIN · CIK 0001236982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,191 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:23 UTC |
Jacks TylerDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018275 · form4.xml · nonDerivative · entry 1 Jacks Tyler · CIK 0001464237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,239 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:24 UTC |
LEWENT JUDY CDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018276 · form4.xml · nonDerivative · entry 1 LEWENT JUDY C · CIK 0001140890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,188 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:26 UTC |
LYNCH THOMAS JDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018278 · form4.xml · nonDerivative · entry 1 LYNCH THOMAS J · CIK 0001208323 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,648 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:28 UTC |
MANZI JIM PDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018279 · form4.xml · nonDerivative · entry 1 MANZI JIM P · CIK 0001216076 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,152 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:30 UTC |
Parrett William GDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018281 · form4.xml · nonDerivative · entry 1 Parrett William G · CIK 0001418280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,188 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:31 UTC |
SORENSEN LARS REBIENDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018283 · form4.xml · nonDerivative · entry 2 SORENSEN LARS REBIEN · CIK 0001225514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,116 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:31 UTC |
SORENSEN LARS REBIENDirector
|
Tax withholdingCommon Stock | 736 | $86.28 | $63,502.08 |
DisclosureSEC source: 0001127602-13-018283 · form4.xml · nonDerivative · entry 1 SORENSEN LARS REBIEN · CIK 0001225514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,377 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:33 UTC |
ULLIAN ELAINEDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-018284 · form4.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,848 Read SEC document |
| May 22, 2013 Filed May 24, 2013 20:30 UTC |
SPERLING SCOTT MDirector
|
GrantCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-13-022782 · doc1.xml · nonDerivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,653 Read SEC document |
| May 15, 2013 Filed May 17, 2013 20:39 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 4,000 | $84.43 | $337,720.00 |
DisclosureSEC source: 0001127602-13-017412 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,785 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2012. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.26 to $84.73, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 14, 2013 Filed May 16, 2013 20:34 UTC |
SPERLING SCOTT MDirector
|
Exercise / conversionStock option (Right to Buy) · Derivative | 15,600 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001140361-13-021345 · doc1.xml · derivative · entry 3 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,600 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal installments on November 9, 2007, 2008 and 2009. Read SEC document |
| May 14, 2013 Filed May 16, 2013 20:34 UTC |
SPERLING SCOTT MDirector
|
SaleCommon Stock | 8,000 | $84.65 | $677,200.00 |
DisclosureSEC source: 0001140361-13-021345 · doc1.xml · nonDerivative · entry 2 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,914 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.65 to $84.68, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 14, 2013 Filed May 16, 2013 20:34 UTC |
SPERLING SCOTT MDirector
|
Exercise / conversionCommon Stock | 15,600 | $43.37 | $676,572.00 |
DisclosureSEC source: 0001140361-13-021345 · doc1.xml · nonDerivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2013 Filed Aug 28, 2014 23:34 UTC |
Pesicka Edward ASenior Vice President
|
OtherCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-026760 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,290 F1 · shares: These shares were escheated by the transfer agent. F2 · price: Not applicable to escheated shares. Read SEC document |
| May 07, 2013 Filed May 8, 2013 21:23 UTC |
Thomson Andrew JSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $46.56 | $0.00 |
DisclosureSEC source: 0001127602-13-016163 · form4.xml · derivative · entry 3 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,700 shares Expires 2016-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal installments on November 20, 2010, 2011, and 2012. Read SEC document |
| May 07, 2013 Filed May 8, 2013 21:23 UTC |
Thomson Andrew JSenior Vice President
|
SaleCommon Stock | 12,700 | $83.65 | $1,062,355.00 |
DisclosureSEC source: 0001127602-13-016163 · form4.xml · nonDerivative · entry 2 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,140 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.54 to $83.74, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2013 Filed May 8, 2013 21:23 UTC |
Thomson Andrew JSenior Vice President
|
Exercise / conversionCommon Stock | 12,700 | $46.56 | $591,312.00 |
DisclosureSEC source: 0001127602-13-016163 · form4.xml · nonDerivative · entry 1 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.